Jillian Chapas-Reed

Jillian has 20+ years of biotech, pharma, and CRO experience, including 10+ years focused on biotech Clinical Operations. She comes to Navigator Medicines with a wealth of experience including Rare Disease/Pulmonary/COPD/Allergy/Asthma therapeutics, global Phase I-IV trials, and experience with small molecules and biologics.

Jillian’s previous roles include VP of Clinical Operations at Adiso Therapeutics, managing all aspects of global clinical operations for a Phase Ib ADS051 ulcerative colitis study and pre-clinical small molecule programs NLRP3 & NLRP1. She held the same position at DBV Technologies (food allergy immunotherapy) and Adastra Pharmaceuticals (Precision Oncology/Orphan Diseases). Her leadership in regulatory and QA activities includes authoring FDA annual updates and Orphan Drug updates for Zotiraciclib (ZTR/TG02).

Jillian has an MS in QA and Regulatory Affairs from Temple University and a BS in Biopsychology from Juniata College.